ST
Stephany Yi Tzeng

Elite Scholar

154
Works
5,033
Citations
40
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Stephany Yi Tzeng

Also known as: S. Tzeng, S. Y. Tzeng, S.Y. Tzeng, Stephany T, Stephany Tzeng

154

Total Works

5,033

Citations

40

H-Index

69

i10-Index

Citation & Works Trend by Year
19 years active
Top Research Topics
RNA Interference and Gene Delivery (81) Nanoparticle-Based Drug Delivery (63) Immunotherapy and Immune Responses (47) Cancer Immunotherapy and Biomarkers (40) T-cell and B-cell Immunology (22)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Polymeric nanoparticle gene delivery to reprogram the tumor immune microenvironment in ovarian cancer for an anti-tumor response Acta Biomaterialia 0
2026 Engineering Lipid Nanoparticles through Integrated Compositional and Ligand Targeting Enhances β Cell-Directed RNA Delivery ACS Nano 1
2026 Engineering of episomal plasmid structure to enhance non-viral Poly(beta-amino ester) nanoparticle gene delivery to liver and brain cancer cells PLoS ONE 0
2026 0617 Sequential intratumoral nanoparticle gene delivery of IL-12 and IL-2 with 4-1BBL improves melanoma survival Journal of Investigative Dermatology 0
2026 Data associated with publication: DNA-loaded nanoparticles reprogram the tumor immune microenvironment to treat brain tumors Research Data Repository, Duke University 0
2026 FALCON: Closed-Loop Multi-Objective Optimization of Lipid Nanoparticles for Cell-Selective mRNA Delivery bioRxiv (Cold Spring Harbor Laboratory) 0
2026 Figure S2 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors 0
2026 Figure S3 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors 0
2026 Figure S4 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors 0
2026 Figure S6 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors 0
2026 Figure S5 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors 0
2026 Figure S1 from The CCR6–CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in Tumors 0
2026 Data associated with the publication: Polymeric nanoparticle gene delivery to reprogram the tumor immune microenvironment in ovarian cancer for an anti-tumor response Research Data Repository, Duke University 0
2026 Base editing and nanoparticle transfection of airway cell types essential for treatment of cystic fibrosis JCI Insight 2
2026 Data associated with the publication: Reprogramming the melanoma tumor immune microenvironment via combinatorial signal 2/3 gene delivery Research Data Repository, Duke University 0

Data source: OpenAlex API